Metabolomic biomarkers for hepatocellular carcinoma: A systematic review

Background: Hepatocellular carcinoma (HCC) is a highly malignant cancer which lack of effective diagnosis and prognosis biomarkers, therefore surging studies focused on the metabolite candidates for HCC. The current study was designed to systematically review the metabolic studies for HCC, summarize...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ningning, Yu, Fatao, Yu, Feng, Feng, Yuling, Zhu, Xiaolin, Xie, Zhihui, Zhai, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772637/
https://www.ncbi.nlm.nih.gov/pubmed/35060504
http://dx.doi.org/10.1097/MD.0000000000028510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772637/
https://www.ncbi.nlm.nih.gov/pubmed/35060504
http://dx.doi.org/10.1097/MD.0000000000028510

Ejemplares similares